Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Oncotarget|February 5, 2017
Expression and role of anion exchanger 1 in esophageal squamous cell carcinomaAtsushi Shiozaki, Michihiro Kudou, Daisuke Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Esophago-Gastric Junctional Carcinoma with Intramural Invasion and Cervical Lymph Node Metastasis]Hidekazu Hiramoto, Hirotaka Konishi, Atsushi Shiozaki, et al.
Annals of Surgical Oncology|September 8, 2023
Cancer Stem Cells of Esophageal Adenocarcinoma are Suppressed by Inhibitors of TRPV2 and SLC12A2Atsushi Shiozaki, Hiroyuki Inoue, Hiroki Shimizu, et al.
Diseases of the Colon and Rectum|January 17, 2023
Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon CancerHiroyuki Inoue, Michihiro Kudou, Atsushi Shiozaki, et al.
International Journal of Oncology|August 22, 2019
Effect of low temperature on the regulation of cell volume after hypotonic shock in gastric cancer cellsAtsushi Shiozaki, Yuzo Yamazato, Toshiyuki Kosuga, et al.
Molecular Cancer|January 6, 2019
Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinomaJun Kiuchi, Shuhei Komatsu, Taisuke Imamura, et al.
Scientific Reports|February 22, 2020
Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancerKeiji Nishibeppu, Shuhei Komatsu, Taisuke Imamura, et al.
Anticancer Research|July 24, 2010
Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancerKatsuya Deguchi, Daisuke Ichikawa, Koji Soga, et al.
Hepato-Gastroenterology|April 23, 2011
Prognostic impact of cancer-related symptoms in recurrent gastric cancer patientsToshiyuki Kosuga, Daisuke Ichikawa, Shuhei Komatsu, et al.
Medicine|December 17, 2020
Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: Phase I/II study (TNAC)Atsushi Shiozaki, Michihiro Kudou, Hitoshi Fujiwara, et al.
Pageof 21